CAPRICOR THERAPEUTICS, INC. (CAPR) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -129.42M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-129.42M | (m) |
| 2026-03-31 | (m) | $-114.59M | (m) |
| 2025-12-31 | (m) | $-105.04M | (m) |
| 2025-09-30 | (m) | $-81.99M | (m) |
| 2025-06-30 | (m) | $-69.98M | (m) |
| 2025-03-31 | (m) | $-55.06M | (m) |
| 2024-12-31 | (m) | $-40.47M | (m) |
| 2024-09-30 | (m) | $-34.11M | (m) |
| 2024-06-30 | (m) | $-27.95M | (m) |
| 2024-03-31 | (m) | $-24.31M | (m) |
| 2023-12-31 | (m) | $-22.29M | (m) |
| 2023-09-30 | (m) | $-29.25M | (m) |
| 2023-06-30 | (m) | $-29.23M | (m) |
| 2023-03-31 | (m) | $-28.97M | (m) |
| 2022-12-31 | (m) | $-29.02M | (m) |
| 2022-09-30 | (m) | $-27.49M | (m) |
| 2022-06-30 | (m) | $-25.05M | (m) |
| 2022-03-31 | (m) | $-22.69M | (m) |
| 2021-12-31 | (m) | $-20.02M | (m) |
| 2021-09-30 | (m) | $-18.01M | (m) |
| 2021-06-30 | (m) | $-17.99M | (m) |
| 2021-03-31 | (m) | $-16.72M | (m) |
| 2020-12-31 | (m) | $-13.66M | (m) |
| 2020-09-30 | (m) | $-10.95M | (m) |
| 2020-06-30 | (m) | $-8.64M | (m) |
| 2020-03-31 | (m) | $-7.21M | (m) |
| 2019-12-31 | (m) | $-7.64M | (m) |
| 2019-09-30 | (m) | $-9.43M | (m) |
| 2019-06-30 | (m) | $-11.96M | (m) |
| 2019-03-31 | (m) | $-14.04M | (m) |
| 2018-12-31 | (m) | $-15.19M | (m) |
| 2018-09-30 | (m) | $373.95K | (m) |
| 2018-06-30 | (m) | $1.78M | (m) |
| 2018-03-31 | (m) | $2.43M | (m) |
| 2017-12-31 | (m) | $2.43M | (m) |
| 2017-09-30 | (m) | $-14.39M | (m) |
| 2017-06-30 | (m) | $-16.99M | (m) |
| 2017-03-31 | (m) | $-18.21M | (m) |
| 2016-12-31 | (m) | $-18.81M | (m) |
| 2016-09-30 | (m) | $-17.63M | (m) |
| 2016-06-30 | (m) | $-15.21M | (m) |
| 2016-03-31 | (m) | $-13.65M | (m) |
| 2015-12-31 | (m) | $-12.86M | (m) |
| 2015-09-30 | (m) | $-11.44M | (m) |
| 2015-06-30 | (m) | $-10.07M | (m) |
| 2015-03-31 | (m) | $-8.48M | (m) |
| 2014-12-31 | (m) | $-6.22M | (m) |
| 2014-09-30 | (m) | $-8.59M | (m) |
| 2014-06-30 | (m) | $-8.59M | (m) |
| 2014-03-31 | (m) | $-8.69M | (m) |
| 2013-12-31 | (m) | $-8.89M | (m) |
| 2013-09-30 | (m) | $-1.63M | (m) |
| 2013-06-30 | (m) | $-1.85M | (m) |
| 2013-03-31 | (m) | $-1.60M | (m) |
| 2012-12-31 | (m) | $-1.89M | (m) |
| 2012-09-30 | (m) | $-3.36M | (m) |
| 2012-06-30 | (m) | $-3.93M | (m) |
| 2012-03-31 | (m) | $-4.46M | (m) |
| 2011-12-31 | (m) | $-4.88M | (m) |
| 2011-09-30 | (m) | $-4.02M | (m) |
| 2011-06-30 | (m) | $-4.68M | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $-6.03M | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-12-31 | (m) | $-7.87M | (m) |
| 2008-12-31 | (m) | $-13.13M | (m) |
| 2007-12-31 | (m) | $-10.30M | (m) |
| 2006-12-31 | (m) | $-2.58M | (m) |
| 2005-12-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |